JP-8 jet fuel exposure induces inflammatory cytokines in rat skin

International Immunopharmacology

Volumn 4, Issue 9, 2004, Pages 1159-1169

  Gallucci, Randle M ^a   O'Dell, Sijy K ^a   Rabe, Daniel ^a   Fechter, Laurence D ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

Chemokine; Cytokine; Dermatitis; Inflammation; JP 8 jet fuel

Indexed keywords

ACETONE; ALPHA CHEMOKINE; BETA CHEMOKINE; CYTOKINE; EOTAXIN; FUEL; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN INFLAMMATION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CXC; CYTOKINES; DERMATITIS, CONTACT; DNA PRIMERS; HYDROCARBONS; INFLAMMATION; INTERLEUKIN-1; KERATINOCYTES; MALE; NEUTROPHIL INFILTRATION; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 3142600668     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.05.012     Document Type: Article

References (46)

1. Pfaff J.K., Tollinger B.J., Lantz R.C., Chen H., Hays A.M., Witten M.L. Neutral endopeptidase (NEP) and its role in pathological pulmonary change with inhalation exposure to JP-8 jet fuel. Toxicol. Ind. Health. 12(1):1996;93-103
2. Harris D.T., Sakiestewa D., Robledo R.F., Witten M. Immunotoxicological effects of JP-8 jet fuel exposure. Toxicol. Ind. Health. 13(1):1997;43-55
3. Ullrich S.E. Dermal application of JP-8 jet fuel induces immune suppression. Toxicol. Sci. 52(1):1999;61-67
4. Harris D.T., Sakiestewa D., Titone D., Young R.S., Witten M. JP-8 jet fuel exposure results in immediate immunotoxicity, which is cumulative over time. Toxicol. Ind. Health. 18(2):2002;77-83
5. Riviere J.E., Brooks J.D., Monteiro-Riviere N.A., Budsaba K., Smith C.E. Dermal absorption and distribution of topically dosed jet fuels Jet-A, JP-8, and JP-8(100). Toxicol. Appl. Pharmacol. 160(1):1999;60-75
6. Cooper J.R., Mattie D.R. Developmental toxicity of JP-8 jet fuel in the rat. J. Appl. Toxicol. 16(3):1996;197-200
7. Keil D.E., Warren D.A., Jenny M.J., EuDaly J.G., Smythe J., Peden-Adams M.M. Immunological function in mice exposed to JP-8 jet fuel in utero. Toxicol. Sci. 26:2003;26
8. Pleil J.D., Smith L.B., Zelnick S.D. Personal exposure to JP-8 jet fuel vapors and exhaust at air force bases. Environ. Health Perspect. 108(3):2000;183-192
9. Ullrich S.E., Lyons H.J. Mechanisms involved in the immunotoxicity induced by dermal application of JP-8 jet fuel. Toxicol. Sci. 58(2):2000;290-298
10. McDougal J.N., Pollard D.L., Weisman W., Garrett C.M., Miller T.E. Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol. Sci. 55(2):2000;247-255
11. Kanikkannan N., Jackson T., Sudhan Shaik M., Singh M. Evaluation of skin sensitization potential of jet fuels by murine local lymph node assay. Toxicol. Lett. 116(1-2):2000;165-170
12. Allen D.G., Riviere J.E., Monteiro-Riviere N.A. Identification of early biomarkers of inflammation produced by keratinocytes exposed to jet fuels Jet A, JP-8, and JP-8(100). J. Biochem. Mol. Toxicol. 14(5):2000;231-237
13. Kanikkannan N., Locke B.R., Singh M. Effect of jet fuels on the skin morphology and irritation in hairless rats. Toxicology. 175(1-3):2002;35-47
14. Monteiro-Riviere N., Inman A., Riviere J. Effects of short-term high-dose and low-dose dermal exposure to Jet A, JP-8 and JP-8+100 jet fuels. J. Appl. Toxicol. 21(6):2001;485-494
15. Kabbur M.B., Rogers J.V., Gunasekar P.G., Garrett C.M., Geiss K.T., Brinkley W.W., et al. Effect of JP-8 jet fuel on molecular and histological parameters related to acute skin irritation. Toxicol. Appl. Pharmacol. 175(1):2001;83-88
16. Lupulescu A.P., Birmingham D.J., Pinkus H. An electron microscopic study of human epidermis after acetone and kerosene administration. J. Invest. Dermatol. 60(1):1973;33-45
17. Tagami H., Ogino A. Kerosine dermatitis. Factors affecting skin irritability to kerosine. Dermatologica. 146(2):1973;123-131
18. Upreti R.K., Das M., Shanker R. Dermal exposure to kerosene. Vet. Hum. Toxicol. 31(1):1989;16-20
19. Commitee on Toxicology SoPELfMF Permissible exposure levels for selected military fuel vapors. 1996;National Academy Press, Washington, DC
20. Chao Y.C., Nylander-French L.A. Determination of keratin protein in a tape-stripped skin sample from jet fuel exposed skin. Ann. Occup. Hyg. 48(1):2004;65-73
21. Baynes R.E., Brooks J.D., Budsaba K., Smith C.E., Riviere J.E. Mixture effects of JP-8 additives on the dermal disposition of jet fuel components. Toxicol. Appl. Pharmacol. 175(3):2001;269-281
22. Simeonova P.P., Luster M.I. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12(6):1995;676-683
23. Bruccoleri A., et al. Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology. 25(1):1997;133-141
24. Harris D.T., Sakiestewa D., Robledo R.F., Young R.S., Witten M. Effects of short-term JP-8 jet fuel exposure on cell-mediated immunity. Toxicol. Ind. Health. 16(2):2000;78-84
25. Allen D.G., Riviere J.E., Monteiro-Riviere N.A. Cytokine induction as a measure of cutaneous toxicity in primary and immortalized porcine keratinocytes exposed to jet fuels, and their relationship to normal human epidermal keratinocytes. Toxicol. Lett. 119(3):2001;209-217
26. Luster M.I., Simeonova P.P., Gallucci R.M., Bruccoleri A., Blazka M.E., Yucesoy B., et al. Role of inflammation in chemical-induced hepatotoxicity. Overview of immunotoxicology and current applications to respiratory diseases. Toxicol. Lett. 120(1-3):2001;317-321
27. Alam R. Chemokines in allergic inflammation. J. Allergy Clin. Immunol. 99(3):1997;273-277
28. Baggiolini M., Dewald B., Moser B. Chemokines and leukocyte traffic. Human chemokines: an update. Nature. 392(6676):1998;565-568
29. Sehgal P.B. Interleukin-6: molecular pathophysiology. J. Invest. Dermatol. 94(6 Suppl.):1990;S2-S6
30. Grossman R.M., Krueger J., Yourish D., Granelli-Piperno A., Murphy D.P., May L.T., et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 86(16):1989;6367-6371
31. Koch A.E., Kronfeld-Harrington L.B., Szekanecz Z., Cho M.M., Haines G.K., Harlow L.A., et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology. 61(5-6):1993;239-246
32. Fugger L., Morling N., Bendtzen K., Ryder L., Andersen V., Heilman C., et al. IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. J. Immunogenet. 16(6):1989;461-465
33. Gallucci R.M., Simeonova P.P., Matheson J.M., Kommineni C., Guriel J.L., Sugawara T., et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 14(15):2000;2525-2531
34. Lin Z.Q., Kondo T., Ishida Y., Takayasu T., Mukaida N. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J. Leukoc. Biol. 73(6):2003;713-721
35. Tipton D.A., Flynn J.C., Stein S.H., Dabbous M. Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts. J. Periodontol. 74(12):2003;1754-1763
36. Kimura T., Iwase M., Kondo G., Watanabe H., Ohashi M., Ito D., et al. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Int. Immunopharmacol. 3(10-11):2003;1519-1528
37. Hong S.H., Ondrey F.G., Avis I.M., Chen Z., Loukinova E., Cavanaugh P.F. Jr., et al. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J. 14(11):2000;1499-1507
38. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. U. S. A. 100(4):2003;1751-1756
39. Walch L., Morris P.L. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors. Endocrinology. 143(9):2002;3276-3283
40. Ramos G., Nghiem D.X., Walterscheid J.P., Ullrich S.E. Dermal application of jet fuel suppresses secondary immune reactions. Toxicol. Appl. Pharmacol. 180(2):2002;136-144
41. Wang S., Young R.S., Sun N.N., Witten M.L. In vitro cytokine release from rat type II pneumocytes and alveolar macrophages following exposure to JP-8 jet fuel in co-culture. Toxicology. 173(3):2002;211-219
42. Heyen J.R., Ye S., Finck B.N., Johnson R.W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77(1):2000;138-147
43. Pajkrt D., Camoglio L., Tiel-van Buul M.C., de Bruin K., Cutler D.L., Affrime M.B., et al. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158(8):1997;3971-3977
44. Marshall J.S., Leal-Berumen I., Nielsen L., Glibetic M., Jordana M. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97(4):1996;1122-1128
45. Castell J., Klapproth J., Gross V., Walter E., Andus T., Snyers L., et al. Fate of interleukin-6 in the rat. Involvement of skin in its catabolism. Eur. J. Biochem. 189(1):1990;113-118
46. Rose-John S., Hipp E., Lenz D., Legres L.G., Korr H., Hirano T., et al. Structural and functional studies on the human interleukin-6 receptor. Binding, cross-linking, internalization, and degradation of interleukin-6 by fibroblasts transfected with human interleukin-6-receptor cDNA. J. Biol. Chem. 266(6):1991;3841-3846